Tectonic Therapeutic, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TECX research report →
Companytectonictx.com
Tectonic Therapeutic, Inc. , a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines.
- CEO
- Alise S. Reicin
- IPO
- 2018
- Employees
- 51
- HQ
- Watertown, MA, US
Price Chart
Valuation
- Market Cap
- $544.19M
- P/E
- -6.48
- P/S
- 0.00
- P/B
- 2.35
- EV/EBITDA
- -3.75
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -32.33%
- ROIC
- -39.58%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-74,151,000 · -27.89%
- EPS
- $-4.05 · -3.05%
- Op Income
- $-84,036,000
- FCF YoY
- -1.77%
Performance & Tape
- 52W High
- $36.03
- 52W Low
- $14.39
- 50D MA
- $29.73
- 200D MA
- $22.45
- Beta
- 1.21
- Avg Volume
- 265.81K
Get TickerSpark's AI analysis on TECX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 4, 26 | Ruddy Marcella K. | sell | 1,065 |
| Apr 1, 26 | Ruddy Marcella K. | sell | 1,000 |
| Apr 1, 26 | Nader Francois | other | 20,400 |
| Apr 1, 26 | Nader Francois | other | 0 |
| Mar 6, 26 | Ruddy Marcella K. | sell | 10,000 |
| Mar 6, 26 | McNamara Peter | other | 215 |
| Mar 6, 26 | McNamara Peter | other | 2,500 |
| Mar 6, 26 | McNamara Peter | sell | 6,047 |
| Mar 6, 26 | McNamara Peter | sell | 215 |
| Mar 6, 26 | McNamara Peter | other | 2,500 |
Our TECX Coverage
We haven't published any research on TECX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TECX Report →